Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Venetoclax,Navitoclax
Therapeutic Area : Oncology
Study Phase : Phase I
Sponsor : AbbVie Inc
Deal Size : Not Applicable
Deal Type : Not Applicable
Details : In the Phase 1 study, Venetoclax with Navitoclax and chemotherapy was well tolerated and had promising efficacy in heavily pretreated pediatric patients with ALL and LL.
Brand Name : Undisclosed
Molecule Type : Small molecule
Upfront Cash : Not Applicable
December 06, 2020
Lead Product(s) : Venetoclax,Navitoclax
Therapeutic Area : Oncology
Highest Development Status : Phase I
Sponsor : AbbVie Inc
Deal Size : Not Applicable
Deal Type : Not Applicable
Lead Product(s) : Streptococcus Pneumoniae vaccine
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Study Phase : Undisclosed
Sponsor : Blue Water Vaccines
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Blue Water Licenses Patent Rights for bacterial Vaccine Development
Details : Blue Water Vaccines has entered into an exclusive worldwide license agreement for the development of a Streptococcus Pneumoniae vaccine with St. Jude Children's Research Hospital.
Brand Name : Undisclosed
Molecule Type : Vaccine
Upfront Cash : Undisclosed
February 10, 2020
Lead Product(s) : Streptococcus Pneumoniae vaccine
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Highest Development Status : Undisclosed
Sponsor : Blue Water Vaccines
Deal Size : Undisclosed
Deal Type : Licensing Agreement
LOOKING FOR A SUPPLIER?